Sign In
Home
About Us
Benefits
Pricing
Templeton Apus
Krixos GmbH
Contact Us
Breaking Cancer News A-Z
Health/Pharma Companies
Drugs, Treatments, Trials
Hot Topics
Clinical Trials - Latest News
Other Illnesses & Conditions
Latest Healthcare News
My Settings
Client Requests
Advanced Search
My Viewed Articles
All Cancer News
Acute Lymphoblastic Leukemia
Acute myeloid leukemia
Adenocarcinoma
Adenoid Cystic Carcinoma
Adrenocortical Carcinoma
Anal Cancer
Anaplastic Astrocytoma
Angiosarcoma
Astrocytoma
Basal-Cell Carcinoma
Bladder Cancer
Brain Cancer
Breast Cancer
Cancer Cachexia
Carcinoma
Cervical Cancer
Childhood Cancer
Cholangiocarcinoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Adenocarcinoma
Colorectal Cancer
Craniopharyngioma
Endometrial Cancer
Ependymoma
Esophageal Cancer
Ewing's Sarcoma
Gallbladder Cancer
Germ Cell Tumors
Glioblastoma
Glioma
Hairy Cell Leukemia
Hepatocellular Carcinoma
Hodgkin Lymphoma
Kaposi's Sarcoma
Kidney & Renal Cancer
Laryngeal Cancer
Leukemia
Liver Cancer
Lung Adenocarcinoma
Lung Cancer
Lymphoma
Mantle Cell Lymphoma
MCRPC
Medulloblastoma
Melanoma
Meningioma
Mesothelioma
Metastatic Colon Cancer
Mouth Cancer
Multiple Myeloma
Myelodysplastic Syndrome
Myelofibrosis
Nasopharyngeal Carcinoma
Neuroblastoma
NMIBC
Non-Hodgkin Lymphoma
NSCLC
Oral Cancer
Oropharyngeal Cancer
Osteosarcoma
Ovarian Cancer
Pancreatic Adenocarcinoma
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Penile Cancer
Pheochromocytoma
Prostate Cancer
Retinoblastoma
Rhabdomyosarcoma
Sarcoma
Sarcopenia
Skin Cancer
Small Cell Lung Cancer
Squamous Cell Carcinoma
Stomach (Gastric) Cancer
Synovial Sarcoma
Testicular Cancer
Thymic Carcinoma
Thymoma
Thyroid Cancer
Tongue Cancer
Uterine Cancer
Vulvar Cancer
Waldenstrom Macroglobulinemia
You need to login...
Enter your email:
Enter your password:
If you are not registered...
Subscribe to Cancer Stat:
Sign Up Now:
Your email:
or call us on: +43 (0)1 71 72 8 900
or email:
apus@templetonapus.com
Most viewed
1.
Transcenta Updates Encouraging Efficacy Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ESMO 2024
2.
As blood cancer treatments evolve, so does the patient journey
3.
FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER
4.
Check-up: What's happening with the ASX small cap health stocks?
5.
Amplia Therapeutics allocated FDA fast-tracking for pancreatic cancer drug narmafotinib
6.
Clinical Trial Catalyst
7.
Preoperative MRI-based radiomic nomogram for distinguishing solitary fibrous tumor from angiomatous meningioma: a multicenter study
8.
Enhancing brain tumor detection: a novel CNN approach with advanced activation functions for accurate medical imaging analysis
9.
Tailoring radiation therapy for brain cancer treatment: a personal investigation
10.
Feasibility study of dual-accelerated simultaneous multi-slice imaging in diffusion tensor imaging of glioma
Last updated at 22:12 GMT
Hot News Makers
Health/Pharma Companies
Novo Nordisk
25404.50
Pharvaris
19619.84
Express Scripts
13181.80
Food & Drug Administration
12775.31
Lassogen
10627.47
Royalty Pharma
10044.90
Volpara Health Technologies
8627.81
MedImmune
8546.42
Evotec
7847.54
Adherium
7355.27
Last updated at 21:10 GMT